Clinical Trial Update: A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated lomustine and cytarabine with radiotherapy for leptomeningeal metastasis from malignant melanoma. The study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis From Malignant Melanoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Lomustine (Lomustine)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Leptomeningeal Metastasis From Malignant Melanoma | Phase 1 | Status: TERMINATED